Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Dr. Manabu SODA Postdoctoral fellow, Division of Functional Genomics, Center for Molecular Medicine, Jichi Medical University	Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer (Nature 2007)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Dr. Ryogo MINAMIMOTO Doctor, Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine	4’-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non–Small Cell Lung Cancer (Journal of Nuclear Medicine 2012)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Dr. Makoto MAEMONDO Medical Director, Miyagi Cancer Center	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR(N Engl J Med 2010; 362: 2380-8)
Kiyoko Goto and Paul Bourdarie Scientific Prize Dr. Tetsuya MITSUDOMI Professor, Department of Respiratory Surgery, Department of Surgery, Kinki University Faculty of Medicine	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial(Lancet Oncol 2010;11:121-28)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Dr. Kota KATANODA Chief of Division of Cancer Statistics Integration, Center for Cancer Control and Information Services, National Cancer Center Japan	Population attributable fraction of mortality associated with tobacco smokingin Japan: a pooled analysis of three large-scale cohort studies(Journal of Epidemiology, 2008; 18:251-64)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Dr. Yukinori MATSUO Senior Lecturer, Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University	Evaluation of dynamic tumour tracking radiotherapy with real-time monitoring for lung tumours using a gimbal mounted linac(Radiother Oncol. 2014;112:360-4.)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Kengo TAKEUCHI M.D., Ph.D. Project Leader, Pathology Project for Molecular Targets, The Cancer Institute of Japanese Foundation for Cancer Research	RET, ROS1 and ALK fusions in lung cancer(Nat Med. 2012;18:378-381)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Yu FUJITA M.D., Ph.D. Specially Appointed Researcher, Division of Molecular and Cellular Medicine, National Cancer Center Research Institute. (Research Associate, Division of Respiratory Diseases, Jikei University School of Medicine)	A novel platform to enable inhaled naked RNAi medicine for lung cancer (Scientific Reports, 2013 Nov 25 ;3 :3325.)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Hidemi ITO M.D., Ph.D., M.P.H Section Chief of Division of Molecular Medicine, Aichi Cancer Center Research Institute	Non-filter and filter cigarette consumption and the incidence of lung cancer hy histological type in Japan and the United States: analysis of 30-year data from population-based cancer registries. (International Journal of Cancer. 201L 128(8): 1918-28.)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Koichi TAKAYAMA M.D., Ph.D. Professor, Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine	Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial (Support Care Cancer 2016 Aug;24(8):3495‐ 505)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Takahiro TABUCHI M.D., Ph.D. Associate Chief, Department of Cancer Epidemiology, Cancer Control Center, Osaka International Cancer Institute	Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study (Annals of Oncology, 2013;24(10):2699-704)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Shimpei KUBOTA M.D.,Ph.D. Postdoctoral Fellow of Japan Society for the Promotion of Science, Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo	Whole-Body Profiling of Cancer Metastasis with Single-Cell Resolution (Cell Reports, 2017, 20, 236-250)
Kei TAKAHASHI Ph.D. Project Researcher, Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Tadashi AKIBA, M.D., Ph.D. Executive Director, The Jikei University Chief, The Jikei University Kashiwa Hospital Professor, Division of Thoracic Surgery, Department of Surgery, Graduate School of Medicine, The Jikei University	Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial (Clinical Cancer Research, 2018 Sep 1;24(17):4089-4097)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Sachie HIRATSUKA-NAKAMURA, M.D., Ph.D. Professor, Department of Biochemistry and Molecular Biology, Shinshu University School of Medicine	Hepato-entrained B220+CD11c+NK1.1+cells regulate pre-metastatic niche formation in the lung(EMBO Molecular Medicine, 2018; 10: e8643)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Masahito SHIMOJO, Ph.D. Specially Appointed Associate Professor, Graduate School of Pharmaceutical Sciences, Osaka University	A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer (Scientific Reports volume 9, Article number: 7618 (2019))
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Yujin KUDO, M.D., Ph.D. Assistant Professor, Department of Thoracic Surgery, Tokyo Medical University	Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non small cell lung cancer (Annals of Oncology, 2019 Sep 1;30(9):1521-1530)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Kenichi YOSHIDA, M.D., Ph.D. Wellcome Sanger Institute / Postdoctoral fellow	Tobacco smoking and somatic mutations in human bronchial epithelium (Nature. 2020;578;266-272.)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Kenji CHAMOTO, Ph.D. Department of Immunology and Genomic Medicine Kyoto University Graduate School of Medicine / Associate professor	Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy. (JCI Insight. 2020 Jan 30; 5(2): e133501.Published online 2020 Jan 30.)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Kazuhito FUNAI, M.D., Ph.D. Associate professor, First Department of Surgery, Hamamatsu University School of Medicine	Urinary Fluorescent Metabolite O-Aminohippuric Acid is a Useful Biomarker for Lung Cancer Detection　(Metabolomics、2020 Sep 17;16(10):101. )
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Taiki HAKOZAKI, M.D. Staff Physician, Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital	The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (Cancer Immunol Res. 2020;8(10):1243-1250.)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Hisashi SAJI, M.D., Ph.D. Professor & Chair, Department of Thoracic Surgery, St. Marianna University School of Medicine	Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial (Lancet. 2022 Apr 23;399(10335):1607-1617.)
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Hiroshi ICHISE, Ph.D. Visiting fellow, National Institute of Allergy and Infectious Diseases, National Institutes of Health	Functional visualization of NK cell-mediated killing of metastatic single tumor cells (eLife, 2022; 11, e76269 (1-28))
Kiyoko Goto and Paul Bourdarie Scientific Prize-Special award Yoshihisa KOBAYASHI, M.D., Ph.D. Staff Scientist, Division of Molecular Pathology, National Cancer Center Research Institute	Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers. (Nature 2022; 603(7900):335-342.)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Kentaro TANAKA, M.D., Ph.D. Associate Professor, Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University (position on April 1st 2024, Associate Professor, Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University)	Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer (Science Translational Medicine 2022;14 (675):eabq0021)
Kiyoko Goto and Paul Bourdarie Scientific Prize Fumihiro SHOJI, M.D., Ph.D. Chief of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center	Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer (Frontiers in Molecular Bioscience 2022, 9:1040424)

Laureates	Paper

Kiyoko Goto and Paul Bourdarie Scientific Prize Masahiro TSUBOI, M.D., Ph.D. Director and Chair, Department of Thoracic Surgery , National Cancer Center Hospital East	Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC (The New England Journal of Medicine：2023 Jul 13;389(2):137-147.)
Kiyoko Goto and Paul Bourdarie Scientific Prize -Special Award Tomotaka UGAI, M.D., Ph.D. Instructor, Harvard Medical School and Brigham and Women’s Hospital Department Associate, Harvard T.H. Chan School of Public Health	Is early-onset cancer an emerging global epidemic? Current evidence and future implication. (Nature Review Clinical Oncology：2022 Oct;19(10):656-673.)